DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,249,000 | -23.9% | 663,050 | -5.5% | 0.25% | -19.3% |
| Q2 2019 | $4,272,000 | +5.8% | 701,445 | +0.9% | 0.30% | +3.7% |
| Q1 2019 | $4,037,000 | -100.0% | 694,908 | -0.2% | 0.29% | -61.2% |
| Q4 2018 | $9,374,365,000 | -30.7% | 696,461 | -0.1% | 0.76% | -13.2% |
| Q3 2018 | $13,536,282,000 | -15.8% | 697,387 | +10.9% | 0.87% | -24.9% |
| Q2 2018 | $16,071,770,000 | +25.7% | 628,786 | -0.9% | 1.16% | +21.3% |
| Q1 2018 | $12,790,233,000 | +9.7% | 634,751 | +9.2% | 0.96% | +5.5% |
| Q4 2017 | $11,663,259,000 | +7.6% | 581,129 | +11.0% | 0.91% | -1.4% |
| Q3 2017 | $10,838,496,000 | +1120.6% | 523,346 | +1550.8% | 0.92% | +839.8% |
| Q3 2016 | $887,973,000 | – | 31,702 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |